The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Real Estate Developers Eye Boston’s South End for Life Science Campus November 13, 2017 Mirati Therapeutics Reports Second Quarter 2017 Financial Results August 3, 2017 Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ January 21, 2018